Detailed price information for Thor Explorations Ltd (THX-X) from The Globe and Mail including charting and trades.

AD, a Phase 2 study to investigate sabirnetug (ACU193) for the treatment of early Alzheimer’s disease, to complete enrollment in the first half of 2025Expect to announce topline results of Phase 1 ...

TauRx Pharma's effort to bring a tau-targeting drug for Alzheimer's disease (AD) to market has been a marathon, with a number of setbacks over the years, but the company reckons it may finally be ...

Using cryo-electron tomography (cryo-ET) and proteomics, this study identifies the tethering of pathological tau filaments within defined brain extracellular vesicles in Alzheimer’s disease ...

Kaizer Chiefs are monitoring Percy Tau as the Bafana Bafana attacker looks set to leave Al Ahly. Kaizer Chiefs are keeping an eye on Percy Tau. The Al Ahly attacker is planning to leave the ...

Bristol-Myers Squibb has upgraded a long-running alliance with Prothena in Alzheimer’s disease, taking an option on a tau protein-targeting antibody in early-stage clinical development.

After hours: November 29 at 1:02 PM EST Loading Chart for QTRX ...